HF
PRAX icon

HRT Financial’s Praxis Precision Medicines PRAX Stock Holding History

HRT Financial’s Portfolio PRAX Stock Details PRAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-14,764
Closed -$900K – 2914
2024
Q1 		$900K Buy
+14,764
New +$662K 0.01% 936
2023
Q1 		– Sell
-7,056
Closed -$251K – 3043
2022
Q4 		$251K Sell
7,056
-6,404
-48% -$200K ﹤0.01% 1833
2022
Q3 		$458K Buy
+13,460
New +$671K ﹤0.01% 1693

Other funds holding PRAX

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

HRT Financial's PRAX Position: Q2 2024 in Review

HRT Financial sold out of Praxis Precision Medicines (PRAX) in Q2 2024, closing a stake of 14,764 shares — an estimated $900K sold.

HRT Financial first reported a position in PRAX in Q3 2022 and held it in 3 quarters. The position peaked at $900K in Q1 2024. 113 funds tracked by Wall St. Rank hold PRAX as of Q2 2024.

  • HRT Financial reported no remaining Praxis Precision Medicines position as of Q2 2024 after selling out during the quarter.
  • HRT Financial sold 14,764 Praxis Precision Medicines shares in Q2 2024, an estimated $900K.
  • HRT Financial first reported a position in Praxis Precision Medicines in Q3 2022 and held it in 3 quarters.
  • HRT Financial's Praxis Precision Medicines position peaked at $900K in Q1 2024.
  • 113 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q2 2024.

Based on HRT Financial's 13F filing for Q2 2024, filed 12 Aug 2024.